These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21498535)

  • 1. The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns about (131)I therapy.
    Goldsmith SJ
    J Nucl Med; 2011 May; 52(5):681-2. PubMed ID: 21498535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possible sequelae of the action of radioactive iodine in man].
    Il'in LA; Arkhangel'skaia GV
    Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelodysplastic syndrome following radioiodine treatment of differentiated carcinoma of the thyroid].
    García Pascual L; Simó R; Mesa J; Galofré P
    Rev Clin Esp; 1992 Jul; 191(3):169-70. PubMed ID: 1502411
    [No Abstract]   [Full Text] [Related]  

  • 6. 131I dosimetry and thyroid stunning.
    Gerard SK; Park HM
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy of carcinoma of the thyroid.
    Howard N; Smithers DW
    Monogr Neoplast Dis Var Sites; 1970; 6():259-68. PubMed ID: 5527677
    [No Abstract]   [Full Text] [Related]  

  • 8. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 9. How safe for the patient is iodine-131 therapy for differentiated thyroid carcinoma?
    Haynie TP; Vassilopoulou-Sellin R
    J Nucl Med; 1995 Jan; 36(1):27-8. PubMed ID: 7799077
    [No Abstract]   [Full Text] [Related]  

  • 10. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
    Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of large therapy doses of 131I in patients with thyroid cancer.
    Singh B; Sharma SM; Patel MC; Raghavendran KV; Berman M
    J Nucl Med; 1974 Aug; 15(8):674-8. PubMed ID: 4841821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
    Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
    Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Consequences of thyroid radiation in children.
    Braverman LE
    N Engl J Med; 1975 Jan; 292(4):204-5. PubMed ID: 1109212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Percutaneous radiotherapy of malignant tumors of the thyroid (author's transl)].
    Scherer E
    Rontgenblatter; 1975 Dec; 28(12):580-6. PubMed ID: 814608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine therapy of toxic adenomas of the thyroid gland].
    Kinser J; Rösler H
    Ther Umsch; 1973 Oct; 30(10):726-33. PubMed ID: 4745946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 20. The usual dose of I-13U used to ablate thyroid.
    Caplan RH; Dvorak D
    J Nucl Med; 1977 Sep; 18(9):946. PubMed ID: 893800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.